REQUEST A DEMO
Total
USD $0.00
Search more companies

Glenmark Pharmaceuticals Sp. z o.o. (Poland)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Glenmark Pharmaceuticals Sp. z o.o. Profile Updated: September 27, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Glenmark Pharmaceuticals Sp. z o.o. is based in Poland. The head office is in Warsaw. The enterprise currently operates in the Other Miscellaneous Nondurable Goods Merchant Wholesalers sector. It was incorporated on July 02, 2008. It currently has a total number of 101 - 250 (2014) employees. The company’s latest financial report indicates a net sales revenue increase of 11.87% in 2024. There was a total growth of 4.89% in Glenmark Pharmaceuticals Sp. z o.o.’s total assets over the same period. The net profit margin of Glenmark Pharmaceuticals Sp. z o.o. increased by 2.02% in 2024.

Headquarters
Ul. Jozefa Piusa Dziekonskiego 3
Warsaw; Mazowieckie; Postal Code: 00-728

Contact Details: Purchase the Glenmark Pharmaceuticals Sp. z o.o. report to view the information.

Website: http://www.glenmark-pharma.pl/

Basic Information
Total Employees:
Purchase the Glenmark Pharmaceuticals Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Glenmark Pharmaceuticals Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Glenmark Pharmaceuticals Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Glenmark Pharmaceuticals Sp. z o.o. report to view the information.
Incorporation Date:
July 02, 2008
Key Executives
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Glenmark Pharmaceuticals Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
11.87%
Total operating revenue
11.72%
Operating profit (EBIT)
58.93%
EBITDA
65.13%
Net Profit (Loss) for the Period
1608.45%
Total assets
4.89%
Total equity
60.07%
Operating Profit Margin (ROS)
0.85%
Net Profit Margin
2.02%
Return on Equity (ROE)
34.01%
Quick Ratio
0.02%
Cash Ratio
-0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?